You Position: Home > Paper

The plasmatic activity changes of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in patients with acute exacerbation of chronic obstructive pulmonary disease

( views:200, downloads:8 )
Author:
No author available
Journal Title:
China Medicine
Issue:
2
DOI:
10.3760/cma.j.issn.1673-4777.2012.02.005
Key Word:
肺疾病,慢性阻塞性;纤溶酶原激活剂;纤溶酶原激活物抑制物1;Pulmonary disease,chronic obstructive;Plasminogen activator;Plasminogen activator inhibitor 1

Abstract: Objective To explore clinical significances of plasma tissue-type plasminogen activator(t-PA) and type 1 plasminogen activator inhibitor ( PAI-1 ) in acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods Two hundred and three patients hospitalized with AECOPD from 2007 to 2010 were chosen as the AECOPD group,while 142 normal persons receiving general health check-up during the same period were arranged for normal control group.Results The value of plasma t-PA in AECOPD patients was significantly lower than that in the normal control group [ (4.4 ± 4.1 ) μg/L vs (7.3 ± 1.4) μg/L,P < 0.01 ] ; and the value of plasma PAI-1 in AECOPD patients was significantly higher than that in the normal control group[ (42 ± 14) μg/L vs ( 19 ±9) μg/L,P < 0.01 ].Conclusions The blood of patients with AECOPD is in a hypercoagulation state,which can easily result in thrombosis of small pulmonary arteries and arterioles.The detection of plasma t-PA and PAI-1 has a certain clinical significance in discovering if there is a hypercoagulation state in AECOPD patients in the early stage.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn